Clinical significance of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Mann
G
G
St. Anna Children's Hospital, Vienna, Austria. georg.mann@stanna.at
Steiner
M
M
Attarbaschi
A
A
D000906:Antibodies / Q000737:chemistry; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000494:pharmacology; D001215:Asparaginase / Q000037:antagonists & inhibitors* / Q000276:immunology* / Q000378:metabolism; D002648:Child; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D016896:Treatment Outcome
D000906:Antibodies; D000970:Antineoplastic Agents; D001215:Asparaginase